Oxidative stress and platelets.

Platelet-dependent thrombus formation may be influenced by alteration of platelet or vascular redox state, the presence of endogenous or exogenous antioxidants, as well as the formation of reactive oxygen and nitrogen species. Specifically, settings and pathways that influence the formation of superoxide and nitric oxide, as well as their metabolism, may influence platelet function and thrombus formation. Although some antioxidant regimens have been associated with bleeding and hemorrhagic stroke, the therapeutic value of antioxidants in clinical syndromes that lead to platelet-dependent thrombosis is not clear, as supplemental antioxidants have not been generally associated with better cardiovascular outcome.

[1]  J. Mehta,et al.  Modulation of ADP-Induced Platelet Activation by Aspirin and Pravastatin: Role of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1, Nitric Oxide, Oxidative Stress, and Inside-Out Integrin Signaling , 2007, Journal of Pharmacology and Experimental Therapeutics.

[2]  D. Granger,et al.  Platelet-associated NAD(P)H oxidase contributes to the thrombogenic phenotype induced by hypercholesterolemia. , 2007, Free radical biology & medicine.

[3]  J. Freedman,et al.  CD40-40L Signaling in Vascular Inflammation* , 2007, Journal of Biological Chemistry.

[4]  G. Salido,et al.  Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets , 2007, Journal of thrombosis and haemostasis : JTH.

[5]  F. Violi,et al.  LDL are oxidatively modified by platelets via GP91phox and accumulate in human monocytes , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  F. Violi,et al.  Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C‐dependent NADPH oxidase activation: effect on platelet recruitment , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  G. Salido,et al.  Endogenously generated reactive oxygen species reduce PMCA activity in platelets from patients with non-insulin-dependent diabetes mellitus , 2006, Platelets.

[8]  Andrew S. Holmes,et al.  Platelet Nitric Oxide Responsiveness: A Novel Prognostic Marker in Acute Coronary Syndromes , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[9]  J. Freedman,et al.  CD40 Ligand Influences Platelet Release of Reactive Oxygen Intermediates , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[10]  J. Freedman,et al.  The Effect of Dipyridamole on Vascular Cell-Derived Reactive Oxygen Species , 2005, Journal of Pharmacology and Experimental Therapeutics.

[11]  U. Walter,et al.  Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway. , 2005, Blood.

[12]  J. Freedman,et al.  Grape Seed and Skin Extracts Inhibit Platelet Function and Release of Reactive Oxygen Intermediates , 2005, Journal of cardiovascular pharmacology.

[13]  G. Salido,et al.  Hydrogen peroxide and peroxynitrite enhance Ca2+ mobilization and aggregation in platelets from type 2 diabetic patients. , 2005, Biochemical and biophysical research communications.

[14]  G. D. Johnston,et al.  Increased superoxide production in hypertensive patients with diabetes mellitus: role of nitric oxide synthase. , 2005, American journal of hypertension.

[15]  G. Ertl,et al.  Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of NO Bioavailability , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[16]  J. Freedman,et al.  Compensatory mechanisms influence hemostasis in setting of eNOS deficiency. , 2005, American journal of physiology. Heart and circulatory physiology.

[17]  Ulrich Pohl,et al.  Reactive Oxygen Species: Players in the Platelet Game , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[18]  F. Violi,et al.  gp91phox-Dependent Expression of Platelet CD40 Ligand , 2004, Circulation.

[19]  M. Yamakuchi,et al.  Nitric Oxide Regulates Exocytosis by S-Nitrosylation of N-ethylmaleimide-Sensitive Factor , 2003, Cell.

[20]  U. Walter,et al.  Dipyridamole Enhances NO/cGMP-Mediated Vasodilator-Stimulated Phosphoprotein Phosphorylation and Signaling in Human Platelets: In Vitro and In Vivo/Ex Vivo Studies , 2003, Stroke.

[21]  M. Furman,et al.  Circulating Monocyte-Platelet Aggregates Are a More Sensitive Marker of In Vivo Platelet Activation Than Platelet Surface P-Selectin: Studies in Baboons, Human Coronary Intervention, and Human Acute Myocardial Infarction , 2001, Circulation.

[22]  T. Morio,et al.  Characterization of soluble CD40 ligand released from human activated platelets. , 2001, Journal of medical and dental sciences.

[23]  M. Roncaglioni Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general Practice , 2001, The Lancet.

[24]  J. Freedman,et al.  α‐Tocopherol and protein kinase C inhibition enhance platelet‐derived nitric oxide release , 2000 .

[25]  S. Yusuf,et al.  Vitamin E supplementation and cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.

[26]  P. Huang,et al.  Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. , 1999, Circulation research.

[27]  J. Loscalzo,et al.  Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes. , 1998, Circulation.

[28]  Reinhold Förster,et al.  CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.

[29]  J. Loscalzo,et al.  Nitric oxide released from activated platelets inhibits platelet recruitment. , 1997, The Journal of clinical investigation.

[30]  J. Loscalzo,et al.  Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. , 1996, The Journal of clinical investigation.

[31]  J. Loscalzo,et al.  Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. , 1995, The Journal of clinical investigation.

[32]  S. Azen,et al.  Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. , 1995, JAMA.

[33]  J. Mehta,et al.  Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. , 1995, The Journal of laboratory and clinical medicine.

[34]  D. Blache Involvement of hydrogen and lipid peroxides in acute tobacco smoking-induced platelet hyperactivity. , 1995, The American journal of physiology.

[35]  S. Barnes,et al.  Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. , 1994, The Journal of biological chemistry.

[36]  S Moncada,et al.  Regulation of Vascular Homeostasis by Nitric Oxide , 1993, Thrombosis and Haemostasis.

[37]  D. Harrison,et al.  Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.

[38]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[39]  L. Raij,et al.  Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. , 1992, The Journal of clinical investigation.

[40]  J. Sixma,et al.  Nitric Oxide Functions as an Inhibitor of Platelet Adhesion Under Flow Conditions , 1992, Circulation.

[41]  A. C. Chan,et al.  Regeneration of vitamin E in human platelets. , 1991, The Journal of biological chemistry.

[42]  M. Lagarde,et al.  Decrease in platelet reduced glutathione increases lipoxygenase activity and decreases vitamin E , 1991, Lipids.

[43]  A. Marcus,et al.  Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. , 1991, The Journal of clinical investigation.

[44]  D. Wood,et al.  Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene , 1991, The Lancet.

[45]  J P Cooke,et al.  Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. , 1990, The American journal of physiology.

[46]  M J Davies,et al.  A macro and micro view of coronary vascular insult in ischemic heart disease. , 1990, Circulation.

[47]  Burch Jw,et al.  Glutathione disulfide production during arachidonic acid oxygenation in human platelets , 1990 .

[48]  G. Vatassery,et al.  Ascorbic acid, glutathione and synthetic antioxidants prevent the oxidation of vitamin E in platelets , 1989, Lipids.

[49]  S. Moncada,et al.  ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM , 1987, The Lancet.

[50]  V. Kakkar,et al.  Selenium enhances prostacyclin production by cultured endothelial cells: possible explanation for increased bleeding times in volunteers taking selenium as a dietary supplement. , 1984, Thrombosis research.

[51]  M J Davies,et al.  Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.

[52]  M. Steiner Effect of Alpha-Tocopherol Administration on Platelet Function in Man , 1983, Thrombosis and Haemostasis.

[53]  M S Golden,et al.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.

[54]  Marcus Aj Pathways of oxygen utilization by stimulated platelets and leukocytes. , 1979 .

[55]  N. Bressler,et al.  Concurrent studies of oxygen consumption and aggregation in stimulated human platelets. , 1979, Blood.

[56]  R. Handin,et al.  Enhancement of platelet function by superoxide anion. , 1977, The Journal of clinical investigation.

[57]  R. Rodvien,et al.  Physiology and Ultrastructure of the Blood Platelet following Exposure to Hydrogen Peroxide , 1976, British journal of haematology.

[58]  P. Ramwell,et al.  Sex and age differences in human platelet aggregation , 1975, Nature.

[59]  J. Freedman,et al.  Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release. , 2004, Thrombosis research.

[60]  F. Violi,et al.  gp 91 phox-Dependent Expression of Platelet CD 40 Ligand , 2004 .

[61]  J. Freedman,et al.  alpha-Tocopherol and protein kinase C inhibition enhance platelet-derived nitric oxide release. , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  J. Mehta,et al.  Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms. , 1996, The Journal of pharmacology and experimental therapeutics.

[63]  U. Ryan,et al.  Potentiation of endogenous nitric oxide with superoxide dismutase inhibits platelet-mediated thrombosis in injured and stenotic arteries. , 1995, Journal of the American College of Cardiology.

[64]  Quansheng Zhou,et al.  Nitric oxide release from resting human platelets. , 1995, Thrombosis research.

[65]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[66]  J. Burch,et al.  Glutathione disulfide production during arachidonic acid oxygenation in human platelets. , 1990, Prostaglandins.

[67]  A. Marcus Pathways of oxygen utilization by stimulated platelets and leukocytes. , 1979, Seminars in hematology.

[68]  H. Holmsen,et al.  Hydrogen peroxide, an inhibitor of platelet function: Effect on adenine nucleotide metabolism, and the release reaction , 1977, American journal of hematology.